DETERMINATION OF ESCITALOPRAM OXALATE IN PHARMACEUTICAL FORMULATION BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Authors

  • Manoj S. Charde Government College of Pharmacy, Kathora Naka, Amrawati-444604 Maharashtra

DOI:

https://doi.org/10.7439/ijpc.v2i1.422

Keywords:

Benign Breast diseases, Fibroadenoma, fibroadenosis, cystosarcoma phylloides

Abstract

A simple, precise and sensitive reverse-phase high performance liquid chromatographic (RP-HPLC) method has been developed for the quantitation of Escitalopram oxalate in pharmaceutical formulations.

Downloads

Author Biography

  • Manoj S. Charde, Government College of Pharmacy, Kathora Naka, Amrawati-444604 Maharashtra
    Assitant Professor

Downloads

Published

2012-04-01

Issue

Section

Research Articles

How to Cite

1.
DETERMINATION OF ESCITALOPRAM OXALATE IN PHARMACEUTICAL FORMULATION BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. Int J of Pharm Chem [Internet]. 2012 Apr. 1 [cited 2025 Jun. 12];2(1):23-6. Available from: https://ssjournals.co.in/index.php/ijpc/article/view/1282